Teneligliptin is non-inferior to sitagliptin for type 2 diabetes (T2DM) inadequately controlled with metformin and glimepiride
ViewAn Open Label, 2 Year Long Term Follow-Up Study to Assess the Efficacy, Safety and Tolerability of Teneligliptin in Indian Subjects with Type 2 Diabetes Mellitus.
ViewA Meta-Analysis and Systematic Review of the Efficacy of Twice Daily (BID) PPIs versus Once Daily (QD) for Treatment of Gastroesophageal Reflux Disease (GERD).
ViewEfficacy and Safety of Teneligliptin in Indian Patients with Inadequately Controlled Type 2 Diabetes Mellitus: A Randomized, Double-blind Study.
ViewIs metformin still the most efficacious first-line oral hypoglycaemic drug in treating type 2 diabetes? A network meta-analysis of randomized controlled trials (RCTs).
ViewManagement of Arterial Hypertension with Angiotensin Receptor Blockers: Current Evidence and the Role of Olmesartan
ViewEfficacy and Safety of Aceclofenac in Osteoarthritis: A Meta-Analysis of Randomized Controlled Trials
ViewThe role of aceclofenac in complex treatment of nonspecific low back pain
ViewComparison of 24 hours Ambulatory Central Blood Pressure Reduction Efficacy between Fixed Amlodipine or Up-titrated Hydrochlorothiazide plus Losartan: The K-Central Study
ViewTeneligliptin in Management of Diabetic Kidney Disease: A Review of Place in Therapy
View